跳至主要内容
临床试验/NCT03937401
NCT03937401Unknown4 期

Use of Oxytocin in MRI-HIFU Treatment

Turku University Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
100
试验地点
1
主要终点
UFS-Qol

研究概览

简要总结

Capability of oxytocin in improving the efficacy of MRI-HIFU is studied. Patients undergoing MRI-HIFU treatment are given oxytocin during treatment and the efficacy of the treatment will be analysed by patient reported symptom questionnaires and imaging data.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients undergoing MRI-HIFU -treatment
  • Patients assessed for suitability to MRI-HIFU treatment
  • willingness to participate in trial

排除标准

  • Known allergy to Syntocinon/oxytocin
  • Elevated blood pressure
  • ischemic heart disease
  • Long QT- interval

研究组 & 干预措施

Patients treated with oxytocin during MRI-HIFU

Experimental

干预措施: Oxytocin (Drug)

结局指标

主要结局

UFS-Qol

时间窗: 12 months after HIFU treatment

Uterine fibroid symptom severity and quality of life (patient quality of life questionnaire)

NPV

时间窗: up to one year

non perfused volume (percentage of fibroid destroyed)

duration of MRI-HIFU

时间窗: up to one year

duration of MRI-HIFU treatment

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验